Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

38,655 stories, page 307 of 645

Advanced search

🌍Aug 8discoverynews.google.comTier 2 · Trade media

Moderna mRNA flu shot wins FDA approval but awaits CDC recommendations

Pharmaceutical TechnologyOriginal source

🌍Aug 8discoverynews.google.comTier 3 · Aggregated media

Mediar and Ono Pharmaceutical to develop fibro-inflammatory treatments

pharmaceutical-business-review.comOriginal source

🌍Aug 8discoverynews.google.comTier 3 · Aggregated media

Legend Biotech Corporation expected to post earnings of 7 cents a share - Earnings Preview

TradingViewOriginal source

🌍Aug 8discoverynews.google.comTier 3 · Aggregated media

Tukaram Mundhe-Led Maharashtra FDA Shuts 2 IIT Bombay Canteens; Here's Why

LatestLYOriginal source

🌍Aug 8Mediacryopak.comTier 2 · Direct publisher

Cold Chain Packaging: From simulation to Laboratory Optimization and Cost-effective Design

CryopakOriginal source

🌍Aug 8discoverynews.google.comTier 3 · Aggregated media

Top Pharmaceutical Stocks To Watch Now - August 7th

MarketBeatOriginal source

🌍Aug 8discoverynews.google.comTier 3 · Aggregated media

Pharmacist-Backed Tips for Choosing High-Quality Supplements

GoodRxOriginal source

🌍Aug 8discoverynews.google.comTier 3 · Aggregated media

Stanford's AI agents designed a drug Merck later built, too

VentureBeatOriginal source

🌍Aug 8discoverynews.google.comTier 3 · Aggregated media

Pfizer and BioNTech Advance Next‑Season Pediatric COVID‑19 Booster Strategy With New Phase 3 Update

TipRanksOriginal source

🇨🇦Aug 8Researchwomenscollegehospital.caTier 2 · Direct publisher

Dr. Fahima Osman receives BPAO Health Innovation & Patient Empowerment Award

Women's College HospitalOriginal source

🌍Aug 8discoverynews.google.comTier 3 · Aggregated media

FDA Cracks Down on Food Safety Violations in Mumbai, Navi Mumbai; Two IIT Bombay Messes Shut, Punjab Grill...

lokmattimes.comOriginal source

🌍Aug 8discoverynews.google.comTier 3 · Aggregated media

Once These Biotech Stocks Settle Down, I’m All Over Them

pro.thestreet.comOriginal source

🌍Aug 8discoverynews.google.comTier 3 · Aggregated media

Celcuity Inc. (CELC) stock price, news, quote and history

Yahoo Finance UKOriginal source

🌍Aug 8discoverynews.google.comTier 3 · Aggregated media

FDA Approves First-in-Class Narcolepsy Drug

LabrootsOriginal source

🌍Aug 8discoverynews.google.comTier 3 · Aggregated media

EyeWorld Weekly, August 7, 2026

EyeWorldOriginal source

🌍Aug 8discoverynews.google.comTier 3 · Aggregated media

FDA Denies Request for Public Hearing on Repeal of Authorizations for FD&C Red No. 3

The National Law ReviewOriginal source

🌍Aug 7discoverynews.google.comTier 3 · Aggregated media

Gavi applauds that the WHO promotes the study of the Ervebo vaccine against the Ebola outbreak in the DRC

DemócrataOriginal source

🌍Aug 7discoverynews.google.comTier 3 · Aggregated media

Teva Pharmaceutical Industries (TEVA) Lifts Outlook On Earnings As Valuation Debate Stays Open

simplywall.stOriginal source

🌍Aug 7discoverynews.google.comTier 3 · Aggregated media

Moderna's mRNA Flu Vaccine Wins FDA Approval

LabrootsOriginal source

🌍Aug 7discoverynews.google.comTier 3 · Aggregated media

Fermenta Biotech Lists on India’s National Stock Exchange

Roastbrief USOriginal source

🌍Aug 7discoverynews.google.comTier 3 · Aggregated media

FDA Cracks Down on Food Safety Violations in Mumbai, Navi Mumbai; Two IIT Bombay Messes Shut, Punjab Grill...

lokmattimes.comOriginal source

🌍Aug 7discoverynews.google.comTier 3 · Aggregated media

Phase III Trial: 8-Week Bemnifosbuvir/Ruzasvir Regimen Matches Standard Hepatitis C Therapy

Medical DialoguesOriginal source

🌍Aug 7discoverynews.google.comTier 2 · Trade media

Soligenix Announces Recent Updates and Second Quarter 2026 Financial Results

BioSpaceOriginal source

🌍Aug 7discoverynews.google.comTier 3 · Aggregated media

FDA approves Takeda’s first-in-class narcolepsy drug

EMJOriginal source

🌍Aug 7discoverynews.google.comTier 2 · Trade media

BlossomHill, Latigo outshine IPO expectations with oversubscribed debuts

Fierce BiotechOriginal source

🌍Aug 7discoverynews.google.comTier 2 · Trade media

‘A chilling effect’: China biotech will slow as it nears R&D frontier, Pfizer’s Baum predicts

Endpoints NewsOriginal source

🌍Aug 7discoverynews.google.comTier 3 · Aggregated media

Gavi welcomes WHO recommendation to include Ervebo vacc

Fresh AngleOriginal source

🌍Aug 7discoverynews.google.comTier 3 · Aggregated media

Teva Pharmaceutical Industries (TEVA) Lifts Outlook On Earnings As Valuation Debate Stays Open

simplywall.stOriginal source

🌍Aug 7discoverynews.google.comTier 3 · Aggregated media

The WHO urges prioritizing the trial of the Ervebo vaccine against Ebola in the outbreak in the Democratic Republic of the Congo.

DemócrataOriginal source

🇺🇸Aug 7CROppd.comTier 2 · Direct publisher

From “transaction expansion” to “certainty-driven expansion”: How can innovative Chinese drugs turn promising assets into global value?

Thermo Fisher PPDOriginal source

🌍Aug 7discoverynews.google.comTier 3 · Aggregated media

Manufacturing Intelligence: Sizing Up Pharma's Biggest AI Deals, Part Two

PharmTech.comOriginal source

🇺🇸Aug 7Research5amventures.comTier 2 · Direct publisher

Latigo Biotherapeutics Announces Pricing of Upsized $345.6 Million Initial Public Offering

5AM VenturesOriginal source

🇺🇸Aug 7Research5amventures.comTier 2 · Direct publisher

CAMP4 advances rare disease treatment for SYNGAP1 into human trials

5AM VenturesOriginal source

🌍Aug 7discoverynews.google.comTier 3 · Aggregated media

Government ‘examining’ medication pack barcode requirements

pharmaceutical-journal.comOriginal source

🌍Aug 7discoverynews.google.comTier 3 · Aggregated media

Claude AI’s Newest Stock Picks Are Also Hedge Fund Favorites: One Breakout Biotech, One AI Chip Bet

Yahoo FinanceOriginal source

🌍Aug 7discoverynews.google.comTier 3 · Aggregated media

FDA authorizes emergency use of Elanco wound spray for screwworm

FeedstuffsOriginal source

🇺🇰Aug 7Regulatorygov.ukTier 1 · Regulatory source

WorkWell Pilots Evaluation Early Implementation Findings

This report presents the emerging findings from the evaluation of the 15 WorkWell programme pilots,...

UK Department of Health and Social CareOriginal source

🌍Aug 7discoverynews.google.comTier 2 · Trade media

Tarsus joins Stargardt race to market with $800m Alkeus takeover

pharmaceutical-technology.comOriginal source

🌍Aug 7discoverynews.google.comTier 3 · Aggregated media

Rohto Pharmaceutical (TSE:4527) Stock Grapples With Revenue Growth And Thinner Margins

simplywall.stOriginal source

🌍Aug 7discoverynews.google.comTier 3 · Aggregated media

FDA Clears Major Regulatory Hurdle as Preservative-Free Ketamine Program Moves Within Reach of Commercialization: NRx Pharmaceuticals: (NAS DAQ: NRXP)

PRLogOriginal source

🌍Aug 7discoverynews.google.comTier 2 · Trade media

Tarsus joins Stargardt race to market with $800m Alkeus takeover

Pharmaceutical TechnologyOriginal source

🌍Aug 7discoverynews.google.comTier 2 · Trade media

Context drops bispecific T-cell engager on cost-cutting initiative

pharmaceutical-technology.comOriginal source

🌍Aug 7discoverynews.google.comTier 2 · Trade media

Fresenius Kabi recalls morphine lot that could lead to death

Fierce PharmaOriginal source

🌍Aug 7discoverynews.google.comTier 3 · Aggregated media

Northwest Biotherapeutics announces MoU with Saudi Pharmaceutical Industries and Medical Appliance Company

BioSpectrum AsiaOriginal source

🌍Aug 7discoverynews.google.comTier 3 · Aggregated media

Fianlimab: Mechanism, Dose, Administration, And Clinical Trials

OncodailyOriginal source

🌍Aug 7discoverynews.google.comTier 3 · Aggregated media

Breakthrough may change treatment for metastatic prostate cancer

Cornell ChronicleOriginal source

🌍Aug 7discoverynews.google.comTier 3 · Aggregated media

Q&A: Where Direct-to-Patient Pharma Stands Today

Pharmaceutical CommerceOriginal source

🌍Aug 7discoverynews.google.comTier 2 · Trade media

BioMarin axes $270M asset after missing phase 3 endpoint

Fierce BiotechOriginal source

🇪🇺Aug 7Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: STRENGTHENING PUBLIC HEALTH EDUCATION IN RESEARCH & EPIDEMIOLOGY IN AFRICA (SPHERE-AFRICA)

CORDISOriginal source

🇪🇺Aug 7Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: Metabolic Hepatoprotection to Enable Curative Cancer Therapy in Patients with Vulnerable Livers

CORDISOriginal source

🇪🇺Aug 7Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: HARNESSING HETEROTYPIC T CELL CLUSTERS TO BOOST TIL CANCER THERAPY

CORDISOriginal source

🇪🇺Aug 7Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: uBeAt-powered closed-loop sTandardisaTion of beatIng heart-on-chip for reliable cardioTOxicity screening

CORDISOriginal source

🌍Aug 7discoverynews.google.comTier 3 · Aggregated media

FDA Launches Small Dispenser Assessment, Grants DSCSA Exemptions

Pharmaceutical CommerceOriginal source

🌍Aug 7discoverynews.google.comTier 3 · Aggregated media

FDA Approval Expands Isatuximab Delivery Options in Multiple Myeloma

HMP Global Learning NetworkOriginal source

🌍Aug 7discoverynews.google.comTier 2 · Trade media

Is the biotech capital of the world moving?

STATOriginal source

🌍Aug 7discoverynews.google.comTier 3 · Aggregated media

Minerva Neurosciences Provides Second Quarter 2026 Financial Results and Business Updates

Investing News NetworkOriginal source

🌍Aug 7discoverynews.google.comTier 2 · Trade media

Novo Nordisk’s CFO on the oral Wegovy rollout and beyond

Fierce BiotechOriginal source

🌍Aug 7discoverynews.google.comTier 3 · Aggregated media

A panoramic overview of China’s pharmaceutical IP protection system

Managing Intellectual PropertyOriginal source

🌍Aug 7discoverynews.google.comTier 3 · Aggregated media

Tudriqev: US FDA Approves Replimune's Skin Cancer Drug After Rejecting It Twice

Health and MeOriginal source

🌍Aug 7discoverynews.google.comTier 3 · Aggregated media

Neurocrine’s Investigational Obesity Drug Targets Three Receptors

Stock TitanOriginal source